Issues associated with the use of phosphospecific antibodies to localise active and inactive pools of GSK-3 in cells

Biology Direct

Volumn 6, Issue , 2011, Pages

  Campa, Victor M ^a   Kypta, Robert M ^a,b  

^a CIC BIOGUNE   (Spain)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; GLYCOGEN SYNTHASE KINASE 3; GLYCOGEN SYNTHASE KINASE 3 ALPHA; GLYCOGEN SYNTHASE KINASE 3 BETA; GREEN FLUORESCENT PROTEIN; ISOENZYME; PHOSPHOSERINE; PHOSPHOSPECIFIC ANTIBODY; PHOSPHOTYROSINE; SMALL INTERFERING RNA;

ARTICLE; CELL; CELL NUCLEUS; ENZYME ACTIVATION; ENZYMOLOGY; FOCAL ADHESION; GENE SILENCING; GENETICS; IMMUNOLOGY; METABOLISM; MITOSIS; PLASMID;

ANTIBODIES, PHOSPHO-SPECIFIC; ANTIGENS; CELL NUCLEUS; CELLS; ENZYME ACTIVATION; FOCAL ADHESIONS; GENE SILENCING; GLYCOGEN SYNTHASE KINASE 3; GREEN FLUORESCENT PROTEINS; ISOENZYMES; MITOSIS; PHOSPHOSERINE; PHOSPHOTYROSINE; PLASMIDS; RNA, SMALL INTERFERING;

EID: 78751647528     PISSN: None     EISSN: 17456150     Source Type: Journal    
DOI: 10.1186/1745-6150-6-4     Document Type: Article

References (30)

1. Doble BW, Woodgett JR. GSK-3: tricks of the trade for a multi-tasking kinase. J Cell Sci 2003, 116:1175-1186. 10.1242/jcs.00384, 3006448, 12615961.
2. Cohen P, Goedert M. GSK3 inhibitors: development and therapeutic potential. Nat Rev Drug Discov 2004, 3:479-487. 10.1038/nrd1415, 15173837.
3. Hur EM, Zhou FQ. GSK3 signalling in neural development. Nat Rev Neurosci 11:539-551. 10.1038/nrn2870, 20648061.
4. Castano Z, Gordon-Weeks PR, Kypta RM. The neuron-specific isoform of glycogen synthase kinase-3beta is required for axon growth. J Neurochem 113:117-130. 10.1111/j.1471-4159.2010.06581.x, 20067585.
5. Hoeflich KP, Luo J, Rubie EA, Tsao MS, Jin O, Woodgett JR. Requirement for glycogen synthase kinase-3beta in cell survival and NF-kappaB activation. Nature 2000, 406:86-90. 10.1038/35017574, 10894547.
6. Kerkela R, Kockeritz L, Macaulay K, Zhou J, Doble BW, Beahm C, Greytak S, Woulfe K, Trivedi CM, Woodgett JR, Epstein JA, Force T, Huggins GS. Deletion of GSK-3beta in mice leads to hypertrophic cardiomyopathy secondary to cardiomyoblast hyperproliferation. J Clin Invest 2008, 118:3609-3618. 10.1172/JCI36245, 2556242, 18830417.
7. Hughes K, Nikolakaki E, Plyte SE, Totty NF, Woodgett JR. Modulation of the glycogen synthase kinase-3 family by tyrosine phosphorylation. Embo J 1993, 12:803-808. 413270, 8382613.
8. Frame S, Cohen P, Biondi RM. A common phosphate binding site explains the unique substrate specificity of GSK3 and its inactivation by phosphorylation. Mol Cell 2001, 7:1321-1327. 10.1016/S1097-2765(01)00253-2, 11430833.
9. Stambolic V, Woodgett JR. Mitogen inactivation of glycogen synthase kinase-3 beta in intact cells via serine 9 phosphorylation. Biochem J 1994, 303(Pt 3):701-704. 1137602, 7980435.
10. Jernigan KK, Cselenyi CS, Thorne CA, Hanson AJ, Tahinci E, Hajicek N, Oldham WM, Lee LA, Hamm HE, Hepler JR, Kozasa T, Linder ME, Lee E. Gbetagamma activates GSK3 to promote LRP6-mediated beta-catenin transcriptional activity. Sci Signal 3:ra37. 10.1126/scisignal.2000647, 20460648.
11. Bijur GN, Jope RS. Proapoptotic stimuli induce nuclear accumulation of glycogen synthase kinase-3 beta. J Biol Chem 2001, 276:37436-37442. 10.1074/jbc.M105725200, 1973163, 11495916.
12. Ryves WJ, Fryer L, Dale T, Harwood AJ. An assay for glycogen synthase kinase 3 (GSK-3) for use in crude cell extracts. Anal Biochem 1998, 264:124-127. 10.1006/abio.1998.2832, 9784196.
13. Wakefield JG, Stephens DJ, Tavare JM. A role for glycogen synthase kinase-3 in mitotic spindle dynamics and chromosome alignment. J Cell Sci 2003, 116:637-646. 10.1242/jcs.00273, 12538764.
14. Kobayashi T, Hino S, Oue N, Asahara T, Zollo M, Yasui W, Kikuchi A. Glycogen synthase kinase 3 and h-prune regulate cell migration by modulating focal adhesions. Mol Cell Biol 2006, 26:898-911. 10.1128/MCB.26.3.898-911.2006, 1347031, 16428445.
15. Bhat RV, Shanley J, Correll MP, Fieles WE, Keith RA, Scott CW, Lee CM. Regulation and localization of tyrosine216 phosphorylation of glycogen synthase kinase-3beta in cellular and animal models of neuronal degeneration. Proc Natl Acad Sci USA 2000, 97:11074-11079. 10.1073/pnas.190297597, 27150, 10995469.
16. Sayas CL, Ariaens A, Ponsioen B, Moolenaar WH. GSK-3 is activated by the tyrosine kinase Pyk2 during LPA1-mediated neurite retraction. Mol Biol Cell 2006, 17:1834-1844. 10.1091/mbc.E05-07-0688, 1415316, 16452634.
17. Cole AR, Sutherland C. Measuring GSK3 expression and activity in cells. Methods Mol Biol 2008, 468:45-65. full_text, 19099245.
18. Bordeaux J, Welsh A, Agarwal S, Killiam E, Baquero M, Hanna J, Anagnostou V, Rimm D. Antibody validation. Biotechniques 48:197-209. 10.2144/000113382, 20359301.
19. Maher MT, Flozak AS, Hartsell AM, Russell S, Beri R, Peled ON, Gottardi CJ. Issues associated with assessing nuclear localization of N-terminally unphosphorylated beta-catenin with monoclonal antibody 8E7. Biol Direct 2009, 4:5. 10.1186/1745-6150-4-5, 2642777, 19187541.
20. Smith D, Sieg S, Kaplan D. Technical note: Aberrant detection of cell surface Fas ligand with anti-peptide antibodies. J Immunol 1998, 160:4159-4160.
21. Cross DA, Alessi DR, Cohen P, Andjelkovich M, Hemmings BA. Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B. Nature 1995, 378:785-789. 10.1038/378785a0, 8524413.
22. Papasozomenos S, Shanavas A. Testosterone prevents the heat shock-induced overactivation of glycogen synthase kinase-3 beta but not of cyclin-dependent kinase 5 and c-Jun NH2-terminal kinase and concomitantly abolishes hyperphosphorylation of tau: implications for Alzheimer's disease. Proc Natl Acad Sci USA 2002, 99:1140-1145. 10.1073/pnas.032646799, 122157, 11805297.
23. Davidson G, Shen J, Huang YL, Su Y, Karaulanov E, Bartscherer K, Hassler C, Stannek P, Boutros M, Niehrs C. Cell cycle control of wnt receptor activation. Dev Cell 2009, 17:788-799. 10.1016/j.devcel.2009.11.006, 20059949.
24. Dajani R, Fraser E, Roe SM, Young N, Good V, Dale TC, Pearl LH. Crystal structure of glycogen synthase kinase 3 beta: structural basis for phosphate-primed substrate specificity and autoinhibition. Cell 2001, 105:721-732. 10.1016/S0092-8674(01)00374-9, 11440715.
25. Cheng TS, Hsiao YL, Lin CC, Yu CT, Hsu CM, Chang MS, Lee CI, Huang CY, Howng SL, Hong YR. Glycogen synthase kinase 3beta interacts with and phosphorylates the spindle-associated protein astrin. J Biol Chem 2008, 283:2454-2464. 10.1074/jbc.M706794200, 18055457.
26. Tighe A, Ray-Sinha A, Staples OD, Taylor SS. GSK-3 inhibitors induce chromosome instability. BMC Cell Biol 2007, 8:34. 10.1186/1471-2121-8-34, 1976608, 17697341.
27. Fumoto K, Lee PC, Saya H, Kikuchi A. AIP regulates stability of Aurora-A at early mitotic phase coordinately with GSK-3beta. Oncogene 2008, 27:4478-4487. 10.1038/onc.2008.92, 18391981.
28. Diehl JA, Cheng M, Roussel MF, Sherr CJ. Glycogen synthase kinase-3beta regulates cyclin D1 proteolysis and subcellular localization. Genes Dev 1998, 12:3499-3511. 10.1101/gad.12.22.3499, 317244, 9832503.
29. Uysal-Onganer P, Kawano Y, Caro M, Walker MM, Diez S, Darrington RS, Waxman J, Kypta RM. Wnt-11 promotes neuroendocrine-like differentiation, survival and migration of prostate cancer cells. Mol Cancer 9:55. 10.1186/1476-4598-9-55, 2846888, 20219091.
30. Smith D, Sieg S, Kaplan D. Aberrant detection of cell surface Fas ligand with anti-peptide antibodies. J. Immunol 1998, 160:4159-4160.